EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-Based Design of HDAC6 Inhibitors Targeting the L2 Pocket: Modulating Autophagy and Liquid−Liquid Phase Separation in Lung Cancer

Simona Barone iD, Abraham Eafa iD, Ivana Bello, Gessica Filocamo, Alessia Alberico, Emilia Cassese, Anna Guadagni, Heiko Rebmann, Emanuela Cosentino iD, Juana Goulart Stollmaier, Aubry K Miller iD, Vincenzo Summa iD und 4 weitere

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.6c02004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Simona Barone und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Department of Excellence 2023-2027, University of Naples Federico II, Via D. Montesano 49, 80131Naples, Italy. Hauptthemen laut MEDLINE: Histone Deacetylase 6, Histone Deacetylase Inhibitors, Lung Neoplasms, Autophagy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Dompé Farmaceutici SpA, NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We herein describe the structure-based design, synthesis and biological evaluation of a new class of histone deacetylase 6 (HDAC6) inhibitors guided by X-ray crystal structures of our previously identified compounds 13-15. X-ray co-crystal structures of second-generation inhibitors 19b (Subseries I) and 20b (Subseries II) within zHDAC6 CD2 confirmed that these compounds behave as highly potent HDAC6 inhibitors with the ability to engage the S531 residue in the L2 loop HDAC6 catalytic domain. Western-blot analysis confirmed the target engagement in cell-based settings, through the increase of acetylated tubulin levels, without significant variation in the histone acetylation status. Compound 20b extensively reduced the viability of A549 cells in both 2- and 3-dimensional cell cultures, through the activation of pro-autophagic pathways. In addition, HDAC6 inhibition impaired the nucleation of stress-granules, confirming the ability of these compounds to modulate liquid−liquid phase separation, an emerging HDAC6-driven hallmark in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase 6Histone Deacetylase InhibitorsLung NeoplasmsAutophagyDrug DesignAntineoplastic AgentsHumansPhase SeparationStructure-Activity RelationshipCrystallography, X-RayA549 Cells

Stichwörter der Autor:innen

autophagyepigeneticshistone deacetylase 6liquid-liquid phase separationlung cancer

Substanzen

Histone Deacetylase 6Histone Deacetylase InhibitorsHDAC6 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Department of Excellence 2023-2027, University of Naples Federico II, Via D. Montesano 49, 80131Naples, Italy.
  • Roy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
  • Exiris s.r.l ., Via di Castel Romano, 100, 00128Rome, Italy.
  • German Cancer Research Center (DKFZ), Cancer Drug Development Group, 69120Heidelberg, Germany.
  • Department of Chemistry and Applied Biosciences, ETH Zürich, 8093Zürich, Switzerland.

ORCID-Profile: Simona Barone, Abraham Eafa, Emanuela Cosentino, Aubry K Miller, Vincenzo Summa, David W Christianson, Margherita Brindisi

Förderung

  • NIGMS NIH HHS
  • Dompé Farmaceutici SpA
  • NextGenerationEU
  • National Institute of General Medical Sciences

Zitieren

APA

Barone, S., Eafa, A., Bello, I., Filocamo, G., Alberico, A., Cassese, E., Guadagni, A., Rebmann, H., Cosentino, E., Stollmaier, J. G., Miller, A. K., Summa, V., Wang, L., Panza, E., Christianson, D. W., & Brindisi, M. (2026). Structure-Based Design of HDAC6 Inhibitors Targeting the L2 Pocket: Modulating Autophagy and Liquid−Liquid Phase Separation in Lung Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02004

Vancouver

Barone S, Eafa A, Bello I, Filocamo G, Alberico A, Cassese E, et al. Structure-Based Design of HDAC6 Inhibitors Targeting the L2 Pocket: Modulating Autophagy and Liquid−Liquid Phase Separation in Lung Cancer. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c02004

BibTeX
@article{Barone2026,
  author = {Barone, Simona and Eafa, Abraham and Bello, Ivana and Filocamo, Gessica and Alberico, Alessia and Cassese, Emilia and Guadagni, Anna and Rebmann, Heiko and Cosentino, Emanuela and Stollmaier, Juana Goulart and Miller, Aubry K and Summa, Vincenzo and Wang, Longlong and Panza, Elisabetta and Christianson, David W and Brindisi, Margherita},
  title = {Structure-Based Design of HDAC6 Inhibitors Targeting the L2 Pocket: Modulating Autophagy and Liquid−Liquid Phase Separation in Lung Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c02004}
}
Kostenlos starten →